Journal of Clinical Microbiology, July 1999, p. 2201-2208, Vol. 37, No. 7
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Laboratoire de
Bactériologie-Virologie-Hygiène,
Received 28 September 1998/Returned for modification 7 December
1998/Accepted 17 March 1999
Burkholderia cepacia, which is an important pathogen in
cystic fibrosis (CF) owing to the potential severity of the infections and the high transmissibility of some clones, has been recently shown
to be a complex of five genomic groups, i.e., genomovars I, II
(B. multivorans), III, and IV and B. vietnamiensis.
B. gladioli is also involved, though rarely, in CF.
Since standard laboratory procedures fail to provide an accurate
identification of these organisms, we assessed the ability of
restriction fragment length polymorphism (RFLP) analysis of
amplified 16S ribosomal DNA (rDNA), with the combination of the
patterns obtained with six endonucleases, to differentiate
Burkholderia species. This method was applied to 16 type
and reference strains of the genus Burkholderia
and to 51 presumed B. cepacia clinical isolates, each
representative of one clone previously determined by PCR ribotyping.
The 12 Burkholderia type strains tested were
differentiated, including B. cepacia, B. multivorans, B. vietnamiensis, and B. gladioli, but neither the genomovar I and III reference strains
nor the genomovar IV reference strain and B. pyrrociniaT were distinguishable. CF clinical
isolates were mainly distributed in RFLP group 2 (which includes
B. multivoransT) and RFLP group 1 (which
includes B. cepacia genomovar I and III reference strains,
as well as nosocomial clinical isolates). Two of the five highly
transmissible clones in French CF centers belonged to RFLP group 2, and
three belonged to RFLP group 1. The remaining isolates either clustered
with other Burkholderia species (B. cepacia
genomovar IV or B. pyrrocinia, B. vietnamiensis, and B. gladioli) or harbored unique
combinations of patterns. Thus, if further validated by hybridization
studies, PCR-RFLP of 16S rDNA could be an interesting identification
tool and contribute to a better evaluation of the respective clinical
risks associated with each Burkholderia species or
genomovar in patients with CF.
uvre-les-Nancy,2 France
*
Corresponding author. Mailing address: Laboratoire de
Bactériologie-Virologie-Hygiène, CHU Rangueil, 1 avenue
Jean Poulhès, 31403 Toulouse Cedex 4, France. Phone:
33-5-61-32-21-55. Fax: 33-5-61-32-26-20. E-mail:
segonds{at}cict.fr.
Present address: Laboratoire d'Ecologie Microbienne de la
Rhizosphère, DSV-DEVM, UMR CNRS-CEA, Commissariat à
l'Energie Atomique, Centre de Cadarache, 13108 Saint Paul-lez-Durance
Cedex, France.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|